Professor, Head of the Department of Clinical Immunology and Allergology
Профессор, заведующая кафедрой клинической иммунологии и аллергологии
Department of Clinical Immunology and Allergology
Кафедра клинической иммунологии и аллергологии
Department of Clinical Immunology and Allergology
Кафедра клинической иммунологии и аллергологии
Department of Clinical Immunology and Allergology
Кафедра клинической иммунологии и аллергологии
It is established that in most of patients the course of atopic bronchial asthma occurs as clinical attacks of expiratory asphyxia repeated both by day and at night. In children aged 1 to 6 the course of this disease is principally slight, medium and grave. In elder age group (7—15 years) the share ef graver forms of bronchial asthma increases. The disease is determined by increased sensitivity to domestic allergens. Atypical forms are found only in young age group and obviously are not connected with hypersensitivity. The specific immunotherapy is an effective treatment method of the classical atopic bronchial asthma in children aged 7 to 15.
Эпидемиологические исследования распространенности аллергических заболеваний, проведенные во многих странах мира, свидетельствуют о том, что в последние годы бронхиальная астма стала одним из наиболее часто встречающихся заболеваний респираторного тракта. Среди детей ее частота достигла 10%.